Lv1
20 积分 2025-01-07 加入
THSD7A as a Promising Biomarker for Membranous Nephrosis
1天前
已完结
Significance of the total renal chronicity score in predicting renal outcome in PLA2R-associated membranous nephropathy
1天前
已完结
Malignancy-associated membranous nephropathy: focus on diagnosis and treatment
2天前
已完结
Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review
1个月前
已完结
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
1个月前
已完结
Isatuximab in combination with carfilzomib and dexamethasone in 1q21+ patients with relapsed/refractory multiple myeloma: Long‐term outcomes in the Phase 3 IKEMA study
1个月前
已完结
Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohort
1个月前
已完结
Clinical characteristics and prognosis of a Chinese cohort with systemic light chain amyloidosis: a single-center study
1个月前
已完结
Risk factors, treatments and outcomes of patients with light chain amyloidosis who relapse after autologous stem cell transplantation
1个月前
已完结
Dysbiosis of gut microbiota in adult idiopathic membranous nephropathy with nephrotic syndrome
3个月前
已完结
皖公网安备34019202002308
